Lori Goltermann
Known title: CEO, Regions & North AmericaCIK: 0002062798
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Aon expands war risk insurance as peers report strong Q1. Aon is deepening its support for Ukraine war risk insurance, a move that highlights the company's role in complex global risk management. This development comes as rival Marsh McLennan reported better-than-expected first-quarter results, intensifying competition within the insurance brokerage sector. With Aon's stock trading near its 52-week high, investors are watching how these operational updates and peer performance will shape upcoming earnings expectations.
Transaction History
| LFST | ▲ Buy | Grant | 35,492 | $0 | 7/2/2026 | View on chart |
| AON | ▲ Buy | Option Exercise | 228 | — | 3/13/2026 | View on chart |
| AON | ▼ Sell | Tax Withholding | 99 | $32K | 3/13/2026 | View on chart |
| AON | ▲ Buy | Option Exercise | 290 | — | 3/13/2026 | View on chart |
| AON | ▼ Sell | Tax Withholding | 126 | $41K | 3/13/2026 | View on chart |
| AON | ▼ Sell | Tax Withholding | 2,713 | $853K | 2/12/2026 | View on chart |
| AON | ▲ Buy | Grant | 6,937 | — | 2/12/2026 | View on chart |
| AON | ▼ Sell | Tax Withholding | 68 | $24K | 11/21/2025 | View on chart |
| AON | ▲ Buy | Option Exercise | 156 | — | 11/21/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.